Potential Drug-Drug Interactions in Patients with coronary Artery Disease

被引：0
|
作者：
S. R. Secoli
N. Danzi
G. Lorenzi-Filho
L. César
F. Nunes
A. Amaro
L. Drager
A. M. M. Reis
机构：
[1] School of Nursing - University of Sao Paulo,Department of Medical
[2] Heart Institute of the School of Medicine Hospital of the University of São Paulo,Surgical Nursing
[3] School of Pharmacy,Federal University of Minas Gerais
来源：
Drug Safety | 2008年 / 31卷
关键词：
Coronary Artery Disease; Drug Interaction; Patient Medical Record; Primary Risk Factor; Australian Community;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：885 / 885
相关论文
共 50 条
  • [1] Potential Drug-Drug Interactions in Patients with Coronary Artery Disease
    Secoli, S. R.
    Danzi, N.
    Lorenzi-Filho, G.
    Cesar, L.
    Nunes, F.
    Amaro, A.
    Drager, L.
    Reis, A. M. M.
    DRUG SAFETY, 2008, 31 (10) : 921 - 921
  • [2] Prevalence, Predictors and Outcomes of Potential Drug-Drug Interactions in Patients with Coronary Artery Disease: a Cross Sectional Study
    Haq, Inamul
    Ismail, Mohammad
    Khan, Fahadullah
    Khan, Qasim
    Ali, Zahid
    Noor, Sidra
    LATIN AMERICAN JOURNAL OF PHARMACY, 2019, 38 (07): : 1458 - 1466
  • [3] Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments
    Fokter, Nina
    Mozina, Martin
    Brvar, Miran
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (3-4) : 81 - 88
  • [4] Potential Drug-Drug Interactions and Admissions Due to Drug-Drug Interactions in Patients Treated in Medical Departments
    Fokter, N.
    Mozina, M.
    Bone, M.
    Brvar, M.
    CLINICAL TOXICOLOGY, 2009, 47 (05) : 496 - 497
  • [5] Factors associated with clinically relevant drug-drug interactions with statins in outpatients with coronary artery disease
    Domingos dos Santos, Jessica Nathalia
    Souza Groia Veloso, Ronara Camila
    Tinoco, Marlon Silva
    Moreira Reis, Adriano Max
    MUNDO DA SAUDE, 2020, 44 (01): : 506 - 514
  • [6] Potential QT-prolonging drug-drug interactions in cardiovascular disease patients
    Kovacevic, Milena
    Culafic, Milica
    Jovanovic, Marija
    Kovacevic, Sandra Vezmar
    Vucicevic, Katarina
    Miljkovic, Branislava
    Stevanovic, Predrag
    Radovanovic, Slavica
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2025, 61
  • [7] Risk factors for potential drug-drug interactions of statins in patients with acute coronary syndrome
    Pejcic, Ana, V
    Jankovic, Slobodan M.
    Davidovic, Goran
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 58
  • [8] Analysis of potential drug-drug interactions in psychiatric patients
    Mahesh, N. M.
    Ramesh, M.
    Guptha, Raghunatha A.
    Parthasarathi, G.
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2007, 41 (01) : 28 - 34
  • [9] Evaluation of potential drug-drug interactions in psychiatric patients
    Todorova-Nenova, K.
    Zhelyazkova-Savova, M.
    Gancheva, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S258 - S259
  • [10] Potential drug-drug interactions in hospitalised haematological patients
    Fernandez de Palencia Espinosa, Ma Angeles
    Diaz Carrasco, Ma Sacramento
    Sanchez Salinas, Andres
    de la Rubia Nieto, Amelia
    Espuny Miro, Alberto
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (06) : 443 - 453
12345